UBS’s BioAmber Inc. BIOA.WS Stock Holding History

UBS’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1K	Buy	+400	New	+$1.04K	﹤0.01%	10280
2014 Q2	–	Sell	-675	Closed	-$1K	–	11452
2014 Q1	$1K	Buy	+675	New	+$1.57K	﹤0.01%	10343
2013 Q4	–	Sell	-435	Closed	–	–	11463
2013 Q3	$0	Buy	435 +100	+30%	+$75	﹤0.01%	11337
2013 Q2	$0	Buy	+335	New	+$213	﹤0.01%	10250

Other funds holding BIOA.WS

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

UBS's BIOA.WS Position: Q3 2014 in Review

UBS opened a new position in BioAmber Inc. (BIOA.WS) in Q3 2014: 400 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #10280 among its holdings. This is a return to the name: UBS previously reported a position in BIOA.WS as recently as Q1 2014.

UBS first reported a position in BIOA.WS in Q2 2013 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold BIOA.WS as of Q3 2014.

UBS held 400 shares of BioAmber Inc. worth $1K as of Q3 2014.
BioAmber Inc. was a new UBS position in Q3 2014.
BioAmber Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10280 holding.
UBS first reported a position in BioAmber Inc. in Q2 2013 and has held it in 4 quarters since.
12 funds tracked by Wall St. Rank held BioAmber Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.